User contributions for Javaria Anwer
Jump to navigation
Jump to search
10 May 2021
- 05:0605:06, 10 May 2021 diff hist +6 Hepatitis C pathophysiology →Mechanisms involved in extra-hepatic manifestations
- 05:0505:05, 10 May 2021 diff hist +2,557 Hepatitis C pathophysiology →Mechanisms involved in extra-hepatic manifestations
9 May 2021
- 10:0110:01, 9 May 2021 diff hist +1,698 Hepatitis C pathophysiology →Histology
1 May 2021
- 17:4817:48, 1 May 2021 diff hist +353 Hepatitis C medical therapy →Treatment Indications & Contraindications
- 17:4617:46, 1 May 2021 diff hist +794 Hepatitis C medical therapy →Treatment Indications & Contraindications
- 17:2017:20, 1 May 2021 diff hist −6 Hepatitis C natural history →Extrahepatic complications of HCV infection
- 17:1917:19, 1 May 2021 diff hist −1 Hepatitis C natural history →Extrahepatic complications of HCV infection
- 17:1917:19, 1 May 2021 diff hist +1,756 Hepatitis C natural history →Extrahepatic complications of HCV infection
- 16:1416:14, 1 May 2021 diff hist +3 Hepatitis C natural history →Extrahepatic complications of HCV infection
- 16:0616:06, 1 May 2021 diff hist +3 Hepatitis C natural history →Extrahepatic complications of HCV infection
- 16:0516:05, 1 May 2021 diff hist +1,006 Hepatitis C natural history →Extrahepatic complications of HCV infection
- 05:4505:45, 1 May 2021 diff hist 0 Hepatitis C medical therapy →HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C; by Infectious Disease Society of America {{cite web |url=https://www.hcvguidelines.org/ |title=Recommendations for Testing, Managing, and Treating Hepatitis C | HCV Guidance |format= |work= |accessdate=}}
- 05:4505:45, 1 May 2021 diff hist +540 Hepatitis C medical therapy →HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C; by Infectious Disease Society of America {{cite web |url=https://www.hcvguidelines.org/ |title=Recommendations for Testing, Managing, and Treating Hepatitis C | HCV Guidance |format= |work= |accessdate=}}
- 05:1305:13, 1 May 2021 diff hist +320 Hepatitis C secondary prevention →Important measures to avoid reduce the risk of further hepatic injury include:
- 05:0805:08, 1 May 2021 diff hist 0 Hepatitis C secondary prevention →Important measures to avoid reduce the risk of further hepatic injury include:
- 04:5804:58, 1 May 2021 diff hist +52 Hepatitis C secondary prevention →Important measures to avoid reduce the risk of further hepatic injury include:
- 04:5504:55, 1 May 2021 diff hist +1,563 Hepatitis C secondary prevention →Important measures to avoid reduce the risk of further hepatic injury include:
27 April 2021
26 April 2021
- 02:3302:33, 26 April 2021 diff hist +465 Hepatitis C epidemiology and demographics →Incidence and Prevalence
25 March 2021
- 00:0700:07, 25 March 2021 diff hist 0 N File:Lateral-ankle-ligament-sprain.jpg No edit summary current